Moa Fransson
Director/Miembro de la Junta en ENZYMATICA AB .
Perfil
Moa Fransson is the founder of Bioflow Systems AB.
She is currently the Chief Executive Officer of Genagon Therapeutics AB and Director at Enzymatica AB.
She holds a doctorate degree from the University of Uppsala.
Cargos activos de Moa Fransson
| Empresas | Cargo | Inicio |
|---|---|---|
| ENZYMATICA AB | Director/Miembro de la Junta | 01/05/2022 |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Director Ejecutivo | 01/12/2019 |
Antiguos cargos conocidos de Moa Fransson.
| Empresas | Cargo | Fin |
|---|---|---|
| Bioflow Systems AB | Fundador | - |
Formación de Moa Fransson.
| University of Uppsala | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENZYMATICA AB | Health Technology |
| Empresas privadas | 2 |
|---|---|
Genagon Therapeutics AB
Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Health Technology |
| Bioflow Systems AB |
- Bolsa de valores
- Insiders
- Moa Fransson
